Horobin Joanna Insider Trades

Insider Trading History

Track insider trading activity for Horobin Joanna. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Liquidia
Liquidia LQDA
Director
Holding Value $3.08M 39,637 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422k 5,882 shares
$71.80
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $2.62M 33,755 shares
Last Trade
Aug 19, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$136k 5,000 shares
$27.17
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $3.01M 38,755 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 18,396 shares
$13.59
$77.75
Liquidia
Liquidia LQDA
Director
Holding Value $1.58M 20,359 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 20,359 shares
$12.28
$77.75
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $3.79M 33,195 shares
Last Trade
Jun 07, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$280k 8,500 shares
$32.96
$114.12
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $720k 6,313 shares
Last Trade
Jun 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$280k 8,500 shares
$32.99
$114.12
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $970k 8,500 shares
Last Trade
Jun 07, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$280k 8,500 shares
$32.96
$114.12
Liquidia
Liquidia LQDA
Director
Holding Value $1.56M 20,000 shares
Last Trade
Jun 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 20,000 shares
$8.63
$77.75
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.37M 12,000 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 12,000 shares
$27.67
$114.12
Vyant Bio
Vyant Bio VYNT
Director
Holding Value $4.49k 23,123 shares
Last Trade
Jan 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.03k 7,526 shares
$0.93
$0.19
Cancer Genetics
Cancer Genetics CGIX
Director
Holding Value $360k 77,994 shares
Last Trade
Oct 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.9k 14,285 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Director
Holding Value $15.1k 77,994 shares
Last Trade
Oct 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.9k 14,285 shares
$2.45
$0.19
Cancer Genetics
Cancer Genetics CGIX
Director
Holding Value $294k 63,709 shares
Last Trade
Jul 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.3k 8,092 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Director
Holding Value $12.4k 63,709 shares
Last Trade
Jul 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.6k 8,092 shares
$4.16
$0.19
Liquidia
Liquidia LQDA
Director
Holding Value $1.56M 20,000 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.2k 20,000 shares
$4.86
$77.75
Kymera Therapeutics
Kymera Therapeutics KYMR
Director
Holding Value $1.37M 12,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340k 24,000 shares
$14.18
$114.12
Cancer Genetics
Cancer Genetics CGIX
Director
Holding Value $256k 55,617 shares
Last Trade
Apr 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.3k 6,796 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Director
Holding Value $10.8k 55,617 shares
Last Trade
Apr 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.3k 6,796 shares
$5.20
$0.19
Cancer Genetics
Cancer Genetics CGIX
Director
Holding Value $225k 48,821 shares
Last Trade
Mar 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 43,478 shares
$4.61
$4.61
Vyant Bio
Vyant Bio VYNT
Director
Holding Value $9.47k 48,821 shares
Last Trade
Mar 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 43,478 shares
$8.05
$0.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up